Global Light Therapy Market Report 2023: Increasing use of Light Therapy in the Treatment of Neonatal Jaundice Drives Growth


Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "Global Light Therapy Market Size, Share & Industry Trends Analysis Report By End-use, By Application, By Light Type, By Product, By Regional Outlook and Forecast, 2022 - 2028" report has been added to's offering.

The Global Light Therapy Market size is expected to reach $1.2 billion by 2028, rising at a market growth of 4.7% CAGR during the forecast period.

Key Market Players

List of Companies Profiled in the Report:

  • Beurer GmBH
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Biophotas, Inc. (Celluma)
  • Nature Bright Company
  • Outside In (Cambridge) Ltd. (Lumie)
  • Northern Light Technologies, Inc.
  • Verilux, Inc. (Bear Down Brands, LLC)
  • The Daylight Company Limited
  • Theralight LLC

Light therapy or phototherapy or heliotherapy is defined as the intentional, regular exposure to bright light to treat various medical conditions. This therapy method particularly treats seasonal affective disorder (SAD) as well as problems with the circadian rhythm that control sleep and wakefulness. In addition, the use of UV light to treat skin disorders like neurodermatitis, acne vulgaris, psoriasis, and eczema is known as ultraviolet (UV)light therapy.

Light therapy treats medical illnesses such as neurological disorders, skin problems, jaundice, and others by using sunlight, light-emitting diodes (LED), fluorescent light bulbs, and other sources of light. The therapy makes use of visible light with a range of wavelengths that have beneficial effects on human anatomies, such as red light, blue light, green light, and near-infrared light.

The cells' mitochondria are targeted by red and near-infrared light, which increases cellular energy production and has a therapeutic effect on the body. The green light has been demonstrated to be effective in lowering the frequency and severity of migraines, and blue light has an antibacterial impact, making it usable to treat skin conditions like acne.

Cells present in the retina, namely photosensitive ganglion cells, manages melatonin, a sleep-regulating hormone whose production is inhibited by light and promoted by darkness. The opposite is somewhat true for serotonin, a hormone that has been associated with mood disorders. Therefore, light boxes that provide extremely particular sorts of artificial lighting to the retina are effective for the aim of modifying melatonin levels or timing.

Market Growth Factors

Increasing use of light therapy in the treatment of neonatal jaundice

Neonatal jaundice can be successfully treated with phototherapy. The newborns receive this treatment, where they are subjected to fluorescent light that aids in hastening their recovery. Jaundice in babies is typical, but if it lasts for a long time, doctors will employ phototherapy equipment to cure the condition.

A pediatric medicine journal revealed that more than half of babies experience jaundice. Similarly, the National Health Service estimates that 6out of 10babies are at risk of developing jaundice. In light of this, market growth is anticipated throughout the forecast period.

Growing prevalence of mood disorders and depression

There are connections between physical health and depression. For instance, depression may also result from CVD or cardiovascular diseases and vice versa. According to projections from the World Bank, untreated mental illnesses and depression might result in significant economic losses globally.

As a result, it is anticipated that the use of light therapy will increase dramatically in the future. In addition, light therapy is known to treat seasonal affective disorders (SADs) in particular by raising serotonin levels. Therefore, the help of light therapy in treating depression, SAD, and other mood disorders are promoting the growth of the market.

Market Restraining Factors

Potential skin damage and side effects

Long-term exposure also raises the possibility of getting skin cancer. Since the treatment results in skin lesions, redness, irritation, and rashes, patients with skin cancer and systemic lupus erythematosus should refrain from receiving it. However, with the use of the right light intensity and a controlled therapy duration, together with growing research and improvements, the adverse effects can be reduced, and the performance can be enhanced. But as of now, this therapy's adverse effect is hampering the market's growth.

Scope of the Study

By End-use

  • Home Healthcare
  • Dermatology Clinics

By Application

  • Sleeping Disorders
  • Eczema & Acne Vulgaris
  • Psoriasis
  • Vitiligo
  • Others

By Light Type

  • Blue Light
  • Red Light
  • White Light

By Product

  • Handheld Devices for Skin Treatment
  • Floor & Desk Lamps
  • Light Box
  • Light Therapy Lamps
  • Light Visor
  • Others

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.



Contact Data